Skip to main content
. 2017 Dec 19;39(3):1327–1338. doi: 10.1002/hbm.23920

Table 1.

Demographic and clinical variables

PTSD subjects (n = 25) Trauma‐exposed controls (n = 25) Healthy controls (n = 25) Significance test (df) [p value]
Gender (F/M) 13/12 13/12 13/12 χ2 (2) = 0.00 [1]
Age (years) 34.0 ± 8.4 36.4 ± 8.1 31.7 ± 6.0 F (2, 72) = 2.44 [.095]
Time since trauma (years) 4.61 ± 2.57 4.26 ± 2.45 t (48) = −0.493 [.805]
Years of education 16.16 ± 1.3 15.04 ± 1.5 15.44 ± 2.24 F (2, 72) = 2.76 [.07]
DASS 57.2 ± 32.6 16.2 ± 25.1 9.5 ± 10.3a F (2, 66) = 24.22 [<.001]
CAPS
Lifetime 95.6 ± 25.9 13.0 ± 21.8 t (48) = −12.20 [<.001]
Month 57.0 ± 26.8 6.7 ± 13.5 t (35.4) = −8.38 [<.001]
Week 53.6 ± 27.6 5.8 ± 12.1 t (32.9) = −7.93 [<.001]
IES‐R 45.1 ± 18.5 15.0 ± 21.6 t (48) = −5.30 [<.001]

Note. Mean scores (±standard deviation) for age and DASS clinical score across groups.

CAPS/IES‐R group differences were tested using two‐tailed continuous data significant at p < .05.

a

DASS scores available for only 19 healthy control participants.